img

Global Immuno-oncology Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Immuno-oncology Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Immuno-oncology therapy is a type of cancer treatment that harnesses the body's immune system to target and destroy cancer cells. It includes therapies such as immune checkpoint inhibitors, cancer vaccines, and adoptive T cell therapies.
Global Immuno-oncology Therapy market is projected to reach US$ 1648.7 million in 2029, increasing from US$ 1233 million in 2022, with the CAGR of 4.5% during the period of 2024 to 2029. Demand from Hospitals and Ambulatory Surgical Center are the major drivers for the industry.
The market for immuno-oncology therapy is driven by the growing interest in personalized and targeted cancer treatments and the need for innovative therapies with fewer side effects. The market's growth is also influenced by the approval of new immuno-oncology drugs and ongoing research in cancer immunotherapy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Immuno-oncology Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
BioNTech SE
Allogene Therapeutics
IMAB-I-Mab Biopharma Co., Ltd.
Arcus Biosciences
Gritstone Oncology
Autolus Therapeutics
Rubius Therapeutics
Segment by Type
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines

Segment by Application


Hospitals
Ambulatory Surgical Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Immuno-oncology Therapy market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Immuno-oncology Therapy introduction, etc. Immuno-oncology Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Immuno-oncology Therapy market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Immuno-oncology Therapy
1.1 Immuno-oncology Therapy Market Overview
1.1.1 Immuno-oncology Therapy Product Scope
1.1.2 Immuno-oncology Therapy Market Status and Outlook
1.2 Global Immuno-oncology Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Immuno-oncology Therapy Market Size by Region (2018-2029)
1.4 Global Immuno-oncology Therapy Historic Market Size by Region (2018-2024)
1.5 Global Immuno-oncology Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Immuno-oncology Therapy Market Size (2018-2029)
1.6.1 North America Immuno-oncology Therapy Market Size (2018-2029)
1.6.2 Europe Immuno-oncology Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Immuno-oncology Therapy Market Size (2018-2029)
1.6.4 Latin America Immuno-oncology Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Immuno-oncology Therapy Market Size (2018-2029)
2 Immuno-oncology Therapy Market by Type
2.1 Introduction
2.1.1 Monoclonal Antibodies
2.1.2 Immune Checkpoint Inhibitors
2.1.3 Immune System Modulators
2.1.4 Cancer Vaccines
2.2 Global Immuno-oncology Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Immuno-oncology Therapy Historic Market Size by Type (2018-2024)
2.2.2 Global Immuno-oncology Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Immuno-oncology Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Immuno-oncology Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Immuno-oncology Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Immuno-oncology Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Immuno-oncology Therapy Revenue Breakdown by Type (2018-2029)
3 Immuno-oncology Therapy Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Center
3.1.3 Others
3.2 Global Immuno-oncology Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Immuno-oncology Therapy Historic Market Size by Application (2018-2024)
3.2.2 Global Immuno-oncology Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Immuno-oncology Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Immuno-oncology Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Immuno-oncology Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Immuno-oncology Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Immuno-oncology Therapy Revenue Breakdown by Application (2018-2029)
4 Immuno-oncology Therapy Competition Analysis by Players
4.1 Global Immuno-oncology Therapy Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immuno-oncology Therapy as of 2022)
4.3 Date of Key Players Enter into Immuno-oncology Therapy Market
4.4 Global Top Players Immuno-oncology Therapy Headquarters and Area Served
4.5 Key Players Immuno-oncology Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Immuno-oncology Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Amgen
5.1.1 Amgen Profile
5.1.2 Amgen Main Business
5.1.3 Amgen Immuno-oncology Therapy Products, Services and Solutions
5.1.4 Amgen Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.1.5 Amgen Recent Developments
5.2 AstraZeneca
5.2.1 AstraZeneca Profile
5.2.2 AstraZeneca Main Business
5.2.3 AstraZeneca Immuno-oncology Therapy Products, Services and Solutions
5.2.4 AstraZeneca Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.2.5 AstraZeneca Recent Developments
5.3 Bristol-Myers Squibb
5.3.1 Bristol-Myers Squibb Profile
5.3.2 Bristol-Myers Squibb Main Business
5.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Products, Services and Solutions
5.3.4 Bristol-Myers Squibb Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.3.5 Eli-Lilly Recent Developments
5.4 Eli-Lilly
5.4.1 Eli-Lilly Profile
5.4.2 Eli-Lilly Main Business
5.4.3 Eli-Lilly Immuno-oncology Therapy Products, Services and Solutions
5.4.4 Eli-Lilly Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.4.5 Eli-Lilly Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Immuno-oncology Therapy Products, Services and Solutions
5.5.4 Roche Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.5.5 Roche Recent Developments
5.6 GlaxoSmithKline
5.6.1 GlaxoSmithKline Profile
5.6.2 GlaxoSmithKline Main Business
5.6.3 GlaxoSmithKline Immuno-oncology Therapy Products, Services and Solutions
5.6.4 GlaxoSmithKline Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.6.5 GlaxoSmithKline Recent Developments
5.7 Janssen Biotech
5.7.1 Janssen Biotech Profile
5.7.2 Janssen Biotech Main Business
5.7.3 Janssen Biotech Immuno-oncology Therapy Products, Services and Solutions
5.7.4 Janssen Biotech Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.7.5 Janssen Biotech Recent Developments
5.8 Merck
5.8.1 Merck Profile
5.8.2 Merck Main Business
5.8.3 Merck Immuno-oncology Therapy Products, Services and Solutions
5.8.4 Merck Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.8.5 Merck Recent Developments
5.9 Novartis
5.9.1 Novartis Profile
5.9.2 Novartis Main Business
5.9.3 Novartis Immuno-oncology Therapy Products, Services and Solutions
5.9.4 Novartis Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.9.5 Novartis Recent Developments
5.10 Pfizer
5.10.1 Pfizer Profile
5.10.2 Pfizer Main Business
5.10.3 Pfizer Immuno-oncology Therapy Products, Services and Solutions
5.10.4 Pfizer Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.10.5 Pfizer Recent Developments
5.11 Sanofi
5.11.1 Sanofi Profile
5.11.2 Sanofi Main Business
5.11.3 Sanofi Immuno-oncology Therapy Products, Services and Solutions
5.11.4 Sanofi Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.11.5 Sanofi Recent Developments
5.12 Spectrum Pharmaceuticals
5.12.1 Spectrum Pharmaceuticals Profile
5.12.2 Spectrum Pharmaceuticals Main Business
5.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Products, Services and Solutions
5.12.4 Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.12.5 Spectrum Pharmaceuticals Recent Developments
5.13 Takeda
5.13.1 Takeda Profile
5.13.2 Takeda Main Business
5.13.3 Takeda Immuno-oncology Therapy Products, Services and Solutions
5.13.4 Takeda Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.13.5 Takeda Recent Developments
5.14 BioNTech SE
5.14.1 BioNTech SE Profile
5.14.2 BioNTech SE Main Business
5.14.3 BioNTech SE Immuno-oncology Therapy Products, Services and Solutions
5.14.4 BioNTech SE Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.14.5 BioNTech SE Recent Developments
5.15 Allogene Therapeutics
5.15.1 Allogene Therapeutics Profile
5.15.2 Allogene Therapeutics Main Business
5.15.3 Allogene Therapeutics Immuno-oncology Therapy Products, Services and Solutions
5.15.4 Allogene Therapeutics Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.15.5 Allogene Therapeutics Recent Developments
5.16 IMAB-I-Mab Biopharma Co., Ltd.
5.16.1 IMAB-I-Mab Biopharma Co., Ltd. Profile
5.16.2 IMAB-I-Mab Biopharma Co., Ltd. Main Business
5.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Products, Services and Solutions
5.16.4 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.16.5 IMAB-I-Mab Biopharma Co., Ltd. Recent Developments
5.17 Arcus Biosciences
5.17.1 Arcus Biosciences Profile
5.17.2 Arcus Biosciences Main Business
5.17.3 Arcus Biosciences Immuno-oncology Therapy Products, Services and Solutions
5.17.4 Arcus Biosciences Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.17.5 Arcus Biosciences Recent Developments
5.18 Gritstone Oncology
5.18.1 Gritstone Oncology Profile
5.18.2 Gritstone Oncology Main Business
5.18.3 Gritstone Oncology Immuno-oncology Therapy Products, Services and Solutions
5.18.4 Gritstone Oncology Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.18.5 Gritstone Oncology Recent Developments
5.19 Autolus Therapeutics
5.19.1 Autolus Therapeutics Profile
5.19.2 Autolus Therapeutics Main Business
5.19.3 Autolus Therapeutics Immuno-oncology Therapy Products, Services and Solutions
5.19.4 Autolus Therapeutics Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.19.5 Autolus Therapeutics Recent Developments
5.20 Rubius Therapeutics
5.20.1 Rubius Therapeutics Profile
5.20.2 Rubius Therapeutics Main Business
5.20.3 Rubius Therapeutics Immuno-oncology Therapy Products, Services and Solutions
5.20.4 Rubius Therapeutics Immuno-oncology Therapy Revenue (US$ Million) & (2018-2024)
5.20.5 Rubius Therapeutics Recent Developments
6 North America
6.1 North America Immuno-oncology Therapy Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Immuno-oncology Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Immuno-oncology Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Immuno-oncology Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Immuno-oncology Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Immuno-oncology Therapy Market Dynamics
11.1 Immuno-oncology Therapy Industry Trends
11.2 Immuno-oncology Therapy Market Drivers
11.3 Immuno-oncology Therapy Market Challenges
11.4 Immuno-oncology Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Immuno-oncology Therapy Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Immuno-oncology Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Immuno-oncology Therapy Market Size Share by Region (2018-2024)
Table 4. Global Immuno-oncology Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Immuno-oncology Therapy Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Immuno-oncology Therapy Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Immuno-oncology Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Immuno-oncology Therapy Revenue Market Share by Type (2018-2024)
Table 9. Global Immuno-oncology Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Immuno-oncology Therapy Revenue Market Share by Type (2024-2029)
Table 11. North America Immuno-oncology Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Immuno-oncology Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Immuno-oncology Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Immuno-oncology Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Immuno-oncology Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Immuno-oncology Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Immuno-oncology Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Immuno-oncology Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Immuno-oncology Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Immuno-oncology Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Immuno-oncology Therapy Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Immuno-oncology Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Immuno-oncology Therapy Revenue Market Share by Application (2018-2024)
Table 24. Global Immuno-oncology Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Immuno-oncology Therapy Revenue Market Share by Application (2024-2029)
Table 26. North America Immuno-oncology Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Immuno-oncology Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Immuno-oncology Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Immuno-oncology Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Immuno-oncology Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Immuno-oncology Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Immuno-oncology Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Immuno-oncology Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Immuno-oncology Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Immuno-oncology Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Immuno-oncology Therapy Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Immuno-oncology Therapy Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immuno-oncology Therapy as of 2022)
Table 39. Date of Key Players Enter into Immuno-oncology Therapy Market
Table 40. Global Immuno-oncology Therapy Key Players Headquarters and Area Served
Table 41. Immuno-oncology Therapy Product Solution and Service
Table 42. Global Immuno-oncology Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Amgen Basic Information List
Table 45. Amgen Description and Business Overview
Table 46. Amgen Immuno-oncology Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in Immuno-oncology Therapy Business of Amgen (2018-2024)
Table 48. Amgen Recent Developments
Table 49. AstraZeneca Basic Information List
Table 50. AstraZeneca Description and Business Overview
Table 51. AstraZeneca Immuno-oncology Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in Immuno-oncology Therapy Business of AstraZeneca (2018-2024)
Table 53. AstraZeneca Recent Developments
Table 54. Bristol-Myers Squibb Basic Information List
Table 55. Bristol-Myers Squibb Description and Business Overview
Table 56. Bristol-Myers Squibb Immuno-oncology Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in Immuno-oncology Therapy Business of Bristol-Myers Squibb (2018-2024)
Table 58. Bristol-Myers Squibb Recent Developments
Table 59. Eli-Lilly Basic Information List
Table 60. Eli-Lilly Description and Business Overview
Table 61. Eli-Lilly Immuno-oncology Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in Immuno-oncology Therapy Business of Eli-Lilly (2018-2024)
Table 63. Eli-Lilly Recent Developments
Table 64. Roche Basic Information List
Table 65. Roche Description and Business Overview
Table 66. Roche Immuno-oncology Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in Immuno-oncology Therapy Business of Roche (2018-2024)
Table 68. Roche Recent Developments
Table 69. GlaxoSmithKline Basic Information List
Table 70. GlaxoSmithKline Description and Business Overview
Table 71. GlaxoSmithKline Immuno-oncology Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in Immuno-oncology Therapy Business of GlaxoSmithKline (2018-2024)
Table 73. GlaxoSmithKline Recent Developments
Table 74. Janssen Biotech Basic Information List
Table 75. Janssen Biotech Description and Business Overview
Table 76. Janssen Biotech Immuno-oncology Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in Immuno-oncology Therapy Business of Janssen Biotech (2018-2024)
Table 78. Janssen Biotech Recent Developments
Table 79. Merck Basic Information List
Table 80. Merck Description and Business Overview
Table 81. Merck Immuno-oncology Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in Immuno-oncology Therapy Business of Merck (2018-2024)
Table 83. Merck Recent Developments
Table 84. Novartis Basic Information List
Table 85. Novartis Description and Business Overview
Table 86. Novartis Immuno-oncology Therapy Products, Services and Solutions
Table 87. Revenue (US$ Million) in Immuno-oncology Therapy Business of Novartis (2018-2024)
Table 88. Novartis Recent Developments
Table 89. Pfizer Basic Information List
Table 90. Pfizer Description and Business Overview
Table 91. Pfizer Immuno-oncology Therapy Products, Services and Solutions
Table 92. Revenue (US$ Million) in Immuno-oncology Therapy Business of Pfizer (2018-2024)
Table 93. Pfizer Recent Developments
Table 94. Sanofi Basic Information List
Table 95. Sanofi Description and Business Overview
Table 96. Sanofi Immuno-oncology Therapy Products, Services and Solutions
Table 97. Revenue (US$ Million) in Immuno-oncology Therapy Business of Sanofi (2018-2024)
Table 98. Sanofi Recent Developments
Table 99. Spectrum Pharmaceuticals Basic Information List
Table 100. Spectrum Pharmaceuticals Description and Business Overview
Table 101. Spectrum Pharmaceuticals Immuno-oncology Therapy Products, Services and Solutions
Table 102. Revenue (US$ Million) in Immuno-oncology Therapy Business of Spectrum Pharmaceuticals (2018-2024)
Table 103. Spectrum Pharmaceuticals Recent Developments
Table 104. Takeda Basic Information List
Table 105. Takeda Description and Business Overview
Table 106. Takeda Immuno-oncology Therapy Products, Services and Solutions
Table 107. Revenue (US$ Million) in Immuno-oncology Therapy Business of Takeda (2018-2024)
Table 108. Takeda Recent Developments
Table 109. BioNTech SE Basic Information List
Table 110. BioNTech SE Description and Business Overview
Table 111. BioNTech SE Immuno-oncology Therapy Products, Services and Solutions
Table 112. Revenue (US$ Million) in Immuno-oncology Therapy Business of BioNTech SE (2018-2024)
Table 113. BioNTech SE Recent Developments
Table 114. Allogene Therapeutics Basic Information List
Table 115. Allogene Therapeutics Description and Business Overview
Table 116. Allogene Therapeutics Immuno-oncology Therapy Products, Services and Solutions
Table 117. Revenue (US$ Million) in Immuno-oncology Therapy Business of Allogene Therapeutics (2018-2024)
Table 118. Allogene Therapeutics Recent Developments
Table 119. IMAB-I-Mab Biopharma Co., Ltd. Basic Information List
Table 120. IMAB-I-Mab Biopharma Co., Ltd. Description and Business Overview
Table 121. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Products, Services and Solutions
Table 122. Revenue (US$ Million) in Immuno-oncology Therapy Business of IMAB-I-Mab Biopharma Co., Ltd. (2018-2024)
Table 123. IMAB-I-Mab Biopharma Co., Ltd. Recent Developments
Table 124. Arcus Biosciences Basic Information List
Table 125. Arcus Biosciences Description and Business Overview
Table 126. Arcus Biosciences Immuno-oncology Therapy Products, Services and Solutions
Table 127. Revenue (US$ Million) in Immuno-oncology Therapy Business of Arcus Biosciences (2018-2024)
Table 128. Arcus Biosciences Recent Developments
Table 129. Gritstone Oncology Basic Information List
Table 130. Gritstone Oncology Description and Business Overview
Table 131. Gritstone Oncology Immuno-oncology Therapy Products, Services and Solutions
Table 132. Revenue (US$ Million) in Immuno-oncology Therapy Business of Gritstone Oncology (2018-2024)
Table 133. Gritstone Oncology Recent Developments
Table 134. Autolus Therapeutics Basic Information List
Table 135. Autolus Therapeutics Description and Business Overview
Table 136. Autolus Therapeutics Immuno-oncology Therapy Products, Services and Solutions
Table 137. Revenue (US$ Million) in Immuno-oncology Therapy Business of Autolus Therapeutics (2018-2024)
Table 138. Autolus Therapeutics Recent Developments
Table 139. Rubius Therapeutics Basic Information List
Table 140. Rubius Therapeutics Description and Business Overview
Table 141. Rubius Therapeutics Immuno-oncology Therapy Products, Services and Solutions
Table 142. Revenue (US$ Million) in Immuno-oncology Therapy Business of Rubius Therapeutics (2018-2024)
Table 143. Rubius Therapeutics Recent Developments
Table 144. North America Immuno-oncology Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 145. North America Immuno-oncology Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 146. Europe Immuno-oncology Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 147. Europe Immuno-oncology Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 148. Asia-Pacific Immuno-oncology Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 149. Asia-Pacific Immuno-oncology Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 150. Asia-Pacific Immuno-oncology Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 151. Asia-Pacific Immuno-oncology Therapy Market Share by Region (2018-2024)
Table 152. Asia-Pacific Immuno-oncology Therapy Market Share by Region (2024-2029)
Table 153. Latin America Immuno-oncology Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 154. Latin America Immuno-oncology Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 155. Latin America Immuno-oncology Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 156. Middle East & Africa Immuno-oncology Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 157. Middle East & Africa Immuno-oncology Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 158. Middle East & Africa Immuno-oncology Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 159. Immuno-oncology Therapy Market Trends
Table 160. Immuno-oncology Therapy Market Drivers
Table 161. Immuno-oncology Therapy Market Challenges
Table 162. Immuno-oncology Therapy Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-oncology Therapy Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Immuno-oncology Therapy Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Immuno-oncology Therapy Market Share by Regions: 2022 VS 2029
Figure 4. Global Immuno-oncology Therapy Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Immuno-oncology Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Immuno-oncology Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Immuno-oncology Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Immuno-oncology Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Immuno-oncology Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Monoclonal Antibodies
Figure 11. Global Monoclonal Antibodies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Immune Checkpoint Inhibitors
Figure 13. Global Immune Checkpoint Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Immune System Modulators
Figure 15. Global Immune System Modulators Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Cancer Vaccines
Figure 17. Global Cancer Vaccines Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Global Immuno-oncology Therapy Market Size Share by Type: 2022 & 2029
Figure 19. North America Immuno-oncology Therapy Revenue Market Share by Type (2018-2029)
Figure 20. Europe Immuno-oncology Therapy Revenue Market Share by Type (2018-2029)
Figure 21. Asia-Pacific Immuno-oncology Therapy Revenue Market Share by Type (2018-2029)
Figure 22. Latin America Immuno-oncology Therapy Revenue Market Share by Type (2018-2029)
Figure 23. Middle East and Africa Immuno-oncology Therapy Revenue Market Share by Type (2018-2029)
Figure 24. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Ambulatory Surgical Center Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 26. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Global Immuno-oncology Therapy Market Size Share by Application: 2022 & 2029
Figure 28. North America Immuno-oncology Therapy Revenue Market Share by Application (2018-2029)
Figure 29. Europe Immuno-oncology Therapy Revenue Market Share by Application (2018-2029)
Figure 30. Asia-Pacific Immuno-oncology Therapy Revenue Market Share by Application (2018-2029)
Figure 31. Latin America Immuno-oncology Therapy Revenue Market Share by Application (2018-2029)
Figure 32. Middle East and Africa Immuno-oncology Therapy Revenue Market Share by Application (2018-2029)
Figure 33. Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 34. Global Top 5 and Top 10 Players Immuno-oncology Therapy Market Share in 2022
Figure 35. North America Immuno-oncology Therapy Market Share by Country (2018-2029)
Figure 36. United States Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 37. Canada Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 38. Germany Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 39. France Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 40. U.K. Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 41. Italy Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 42. Russia Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 43. Nordic Countries Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 44. Asia-Pacific Immuno-oncology Therapy Market Share by Region (2018-2029)
Figure 45. China Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 46. Japan Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 47. South Korea Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 48. Southeast Asia Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 49. India Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 50. Australia Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 51. Latin America Immuno-oncology Therapy Market Share by Country (2018-2029)
Figure 52. Mexico Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 53. Brazil Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 54. Middle East & Africa Immuno-oncology Therapy Market Share by Country (2018-2029)
Figure 55. Turkey Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 57. UAE Immuno-oncology Therapy Market Size (2018-2029) & (US$ Million)
Figure 58. Bottom-up and Top-down Approaches for This Report